Influenza Vaccine for Healthy Aging

Food Science and Human Nutrition Department, University of Florida, Gainesville, FL
Healthy AgingInfluenza Vaccine - Biological
50 - 100
All Sexes

Study Summary

This trial will test if a supplement can help the flu vaccine work better.

Eligible Conditions
  • Healthy Aging

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 1

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: 42 days (Day 1, Day 14, Day 15, and day 42)

42 days
Brief Fatigue Inventory (BFI)
Cold and flu symptoms
Gastrointestinal Symptom Rating Scale (GSRS)
Incidence of influenza
Incidence of influenza and Covid-19
Mood and Feelings Questionnaire (MFQ)
Day 42
Antibody Titer
Inflammatory cytokine profile

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Experimental Treatment

Non-Treatment Group

90 Total Participants · 2 Treatment Groups

Primary Treatment: Influenza Vaccine · Has Placebo Group · Phase 1

Beta-glucanExperimental Group · 2 Interventions: Influenza Vaccine, Beta-glucan · Intervention Types: Biological, DietarySupplement
PlaceboPlaceboComparator Group · 2 Interventions: Placebo, Influenza Vaccine · Intervention Types: DietarySupplement, Biological
First Studied
Drug Approval Stage
How many patients have taken this drug
Influenza Vaccine
Completed Phase 4

Trial Logistics


Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 42 days (day 1, day 14, day 15, and day 42)

Who is running the clinical trial?

University of FloridaLead Sponsor
1,274 Previous Clinical Trials
700,076 Total Patients Enrolled
Danstar Ferment AGUNKNOWN

Eligibility Criteria

Age 50 - 100 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are going to receive a flu shot.

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Has the Influenza Vaccine been given an okay from the FDA?

"The influenza vaccine has been evaluated by our team at Power and given a rating of 1 due to the limited data available concerning its safety and effectiveness in this phase 1 trial." - Anonymous Online Contributor

Unverified Answer

Is the age limit for participation in this study above twenty years?

"To be enrolled in this medical trial, patients must fall between the ages of 50 and 100. Younger individuals are able to partake in 41 separate studies, while seniors over 65 have 117 different trials available for them." - Anonymous Online Contributor

Unverified Answer

How many individuals have signed up to take part in this clinical trial?

"Affirmative. According to, this medical trial was posted on October 12th 2021 and recently updated September 12th 2022; 90 patients are currently being recruited from one center of care." - Anonymous Online Contributor

Unverified Answer

Are there any vacant slots in this medical research for participants?

"In accordance with, this trial is searching for participants to take part in the experiment. The initial advertisement was published on 10th December 2021 and was last amended on 9th December 2022." - Anonymous Online Contributor

Unverified Answer

What are the qualifications for enrolling in this research?

"This study is seeking 90 volunteers aged between 50 and 100 who display healthy aging. To be accepted, individuals must agree to follow the trial's procedures - including taking an influenza vaccine and ingesting a supplement given by the researchers - as well as attending scheduled blood draw appointments and completing surveys." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.